相关实验视频

Updated: Jul 6, 2025

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

质母细胞瘤疫苗:过去,现在和机遇

Zujian Xiong¹, Itay Raphael², Michael Olin³

¹Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15201, USA; Xiangya School of Medicine, Central South University, Changsha, Hunan 410008, PR China.

|January 6, 2024

概括

质母细胞瘤 (GBM) 治疗疫苗在结合多种抗原和优化策略时表现有前途. 这种方法可以克服低突变负担的挑战,并提高超出单疫苗的疗效.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
疫苗开发疫苗开发

背景情况:

质母细胞瘤 (GBM) 是一种高度致命的成人中枢神经系统 (CNS) 瘤.
包括瘤疫苗在内的免疫疗法正在探索,以补充各种癌症的标准护理 (SOC).
之前的GBM疫苗研究由于低新抗原标和单疫苗的有效性有限而面临限制.

研究的目的:

审查目前的质母细胞瘤 (GBM) 治疗疫苗平台.
评估GBM免疫疗法的潜在抗原标.
讨论改善GBM疫苗疗效的挑战和机会.

主要方法:

关于质母细胞瘤 (GBM) 治疗疫苗研究的文献综述.
对抗原标的分析,包括新抗原,瘤相关抗原 (TAA) 和病原体衍生抗原.
疫苗设计和疫苗接种策略的评估.

主要成果:

质母细胞瘤 (GBM) 由于低突变负担,对治疗性疫苗接种提出了挑战.
单疫苗在GBM的单疗法中表现出有限的疗效.
结合多种抗原和优化疫苗策略对于增强治疗效果至关重要.

结论:

优化质母细胞瘤 (GBM) 治疗疫苗需要采用多抗原方法.
将新抗原,TAA和病原体衍生的抗原结合起来,可能会提高疫苗的疗效.
为了有效的GBM免疫疗法,需要进一步研究疫苗设计和疫苗接种策略.

关键词:

质母细胞瘤 (glioblastoma) 是一个这是瘤抗原.疫苗的有效性疫苗的有效性疫苗的前景疫苗的前景疫苗平台是一个疫苗平台.

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.